Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 44
Growth YoY: +20.1%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 601–650 of 1,127 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07504263	Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies	not yet recruiting	Phase 1 / Phase 2	66	Recurv Pharma IncINDUSTRY	0	Mar 31, 2026	clinicaltrials
NCT03060720	Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy	active not recruiting	—	271	Dana-Farber Cancer InstituteOTHER	1	Mar 30, 2026	clinicaltrials